Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers
Guardado en:
Autores principales: | Jordi Heijman, Ann-Kathrin Rahm, Dobromir Dobrev |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01212d2745484c668ebc1f58e3c2ec32 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation
por: Divya Guntur, et al.
Publicado: (2021) -
Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Hannan Safiyyah Tan Sian Hui Abdullah, et al.
Publicado: (2021) -
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Jonne Lintunen, et al.
Publicado: (2021) -
Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
por: Noto H, et al.
Publicado: (2013) -
Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons
por: Rebecca Hagan, et al.
Publicado: (2021)